U.S. Healthcare Services Stock News

NYSE:FIS
NYSE:FISDiversified Financial

What Fidelity National Information Services (FIS)'s New Debt Raise and Mizuho Win Means For Shareholders

Earlier in March 2026, Fidelity National Information Services completed multi-currency senior notes offerings totaling US$6.80 billion and €1.00 billion, while Mizuho Financial Group selected FIS’s Balance Sheet Manager to support compliance with Japan’s revised IFRS 9-aligned accounting standards. The combination of expanded financing capacity and a high-profile win with Mizuho underscores how FIS’s software and balance sheet tools are embedded in mission-critical financial infrastructure...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

How Tetra Tech’s (TTEK) New U.S. Navy Contract Shapes Its Defense Infrastructure Narrative

In March 2026, Tetra Tech, Inc. announced that Naval Facilities Engineering Systems Command Southeast selected its joint venture with Mason & Hanger for a US$99 million, five-year single-award task order contract to deliver multidiscipline architect-engineer services supporting resilient U.S. Navy infrastructure across the NAVFAC Southeast area of operations. This win deepens Tetra Tech’s role in defense-related infrastructure, provides multiyear revenue visibility, and could enhance its...
NYSE:OTIS
NYSE:OTISMachinery

Are Otis (OTIS) Viva Upgrades Quietly Redefining Its Service And Modernization Advantage?

Earlier in March 2026, Otis Worldwide introduced its Viva solutions, a suite of elevator upgrades and features designed to improve safety, accessibility and comfort for aging populations, while also coming standard on its Gen3 and Gen360 systems across major global markets. The focus on intergenerational mobility and retrofit-friendly upgrades positions Viva as a way for building owners to extend asset life, meet evolving accessibility standards and enhance passenger experience without full...
NYSE:HAYW
NYSE:HAYWBuilding

Assessing Hayward Holdings (HAYW) Valuation After Recent Share Price Weakness

Event context and recent stock moves Hayward Holdings (HAYW) has been drawing attention after a period of weaker share performance, with the stock showing a 15% decline over the past month and about 11% over the past 3 months. See our latest analysis for Hayward Holdings. Beyond the recent pullback, Hayward’s 1 day, 7 day and 30 day share price returns are all in negative territory. However, the 3 year total shareholder return of about 27% points to a more constructive longer term picture. If...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Assessing Leonardo DRS (DRS) Valuation After Strong Multi‑Year Shareholder Returns

Why Leonardo DRS Stock Is On Investors’ Radar Leonardo DRS (DRS) has drawn fresh attention after recent share moves, with the price at $45.30 and total returns of 30% year to date and 38% over the past year. See our latest analysis for Leonardo DRS. The recent 1-day share price return of a 1.3% decline and 7-day share price return of a 4.5% decline sit against a much stronger backdrop, with a 30-day share price return of 18.8% and a 3-year total shareholder return of about 2.6x. This points...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

How Investors May Respond To Nutanix (NTNX) Investor Day Amid Shifting Institutional Positioning

Nutanix, Inc., a hybrid multicloud software provider, recently presented at the HIMSS 2026 Global Health Conference & Exhibition in Las Vegas and is preparing to host its 2026 Investor Day on April 7 in Chicago, where leadership will outline company strategy and provide a financial update. At the same time, institutional positioning has been shifting, with Schroder Investment Management Group cutting its Nutanix stake by 43.4% while other funds adjust holdings, against a backdrop of debate...
NYSE:RBA
NYSE:RBACommercial Services

A Look At RB Global (RBA) Valuation After Announcing US$500 Million Share Buyback Program

RB Global (RBA) has put a new US$500 million share repurchase plan on the table, targeting up to 10,000,000 shares. The move immediately shifts attention to capital allocation and shareholder returns. See our latest analysis for RB Global. The buyback news comes after a softer period for the shares, with a 7 day share price return of 6.72% and a 90 day share price return of 5.29%. In contrast, the 3 year total shareholder return of 99.05% and 5 year total shareholder return of 91.35% indicate...
NYSE:KWR
NYSE:KWRChemicals

A Look At Quaker Chemical (KWR) Valuation After Recent Share Price Weakness

Quaker Chemical (KWR) has been drawing attention after a period of weaker share performance, with the stock down about 34% over the past month and 14% over the past 3 months. See our latest analysis for Quaker Chemical. Looking beyond the recent slump, Quaker Chemical’s 30-day share price return of 33.95% and year to date share price return of 14.76% contrast with a 1-year total shareholder return of 4.99% and a 5-year total shareholder return of 48.90%. This suggests that shorter term...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Should Radware’s (RDWR) AI-Powered Encrypted DDoS Service Redefine Its Edge in Cloud Security?

In early March 2026, Radware launched its Web DDoS Protection for Encrypted Traffic as a cloud-based service that blocks sophisticated layer 7 DDoS attacks without requiring SSL certificate sharing or traffic decryption, addressing privacy, regulatory, and key management concerns. The company positions this as a first-of-its-kind cloud offering that uses AI-driven behavioral analysis to protect the rising volume of encrypted web traffic across cloud, on-premises, hybrid, and...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Does Tango Therapeutics (TNGX) Trial Pact and ESOP Shelf Hint at a Pivotal Strategic Turn?

Tango Therapeutics, Inc. has reported fourth-quarter 2025 net loss of US$38.75 million and a full-year 2025 net loss of US$101.59 million, alongside full-year revenue of US$62.38 million, while also filing a US$95.67 million common stock shelf registration related to its employee stock ownership plan. Erasca, Inc.’s recent clinical trial collaboration and supply agreement with Tango to combine ERAS-0015 and vopimetostat in MTAP-deleted pancreatic and lung cancers adds an additional layer of...
NasdaqGS:CPB
NasdaqGS:CPBFood

Why Campbell's (CPB) Is Down 14.2% After Weaker Q2, Lowered 2026 Outlook And Snacks Softness

In March 2026, Campbell’s reported softer second-quarter and first-half results, with sales and net income lower than a year earlier, alongside reduced fiscal 2026 guidance and continued weakness in its snacks and bakery businesses. At the same time, Campbell’s has been reshaping its leadership and capital allocation, appointing new heads of supply chain and investor relations while selectively executing share repurchases under two ongoing buyback programs. We’ll now examine how the weaker...
NYSE:PUMP
NYSE:PUMPEnergy Services

ProPetro Holding (PUMP) Is Up 17.4% After Profit Return And Crude Spike - Has The Bull Case Changed?

Earlier in March 2026, ProPetro Holding reported quarterly results that beat analyst expectations and showed a move back into profitability, while crude oil prices climbed sharply following renewed attacks on Middle East energy infrastructure that raised concerns about supply disruptions. This combination of stronger operating performance and a supportive commodity backdrop highlighted how closely ProPetro’s prospects are tied to both execution and broader geopolitical tensions in energy...
NYSE:NBR
NYSE:NBREnergy Services

Can Nabors Industries’ (NBR) Strong Q4 Cash Flows Reframe Its Long-Term Risk‑Reward Profile?

Nabors Industries recently reported its fourth-quarter 2025 results, posting adjusted profit of US$0.17 per share and higher operating revenue year over year, driven by stronger contributions from its International Drilling and Drilling Solutions segments. An interesting aspect of this report is how improved free cash flow generation and segment performance have encouraged analysts to revise their estimates upward and assign a more optimistic outlook for the company. Now we’ll examine how...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

A Look At Pebblebrook Hotel Trust’s (PEB) Valuation After Recent Share Price Weakness

Why Pebblebrook Hotel Trust (PEB) is on investors’ radar today Pebblebrook Hotel Trust (PEB) has drawn investor attention following recent share price moves, with the stock down about 2% over the past week and about 9% over the past month. In this context, the REIT’s latest disclosed revenue of US$1,475.544 million and a reported net loss of US$105.757 million provide a clearer snapshot of the current business profile and risk level. See our latest analysis for Pebblebrook Hotel...
NYSE:RSG
NYSE:RSGCommercial Services

Republic Services (RSG) Valuation Check After Upbeat Q4 Results And Higher Analyst Targets

Why Republic Services (RSG) Is Back on Investor Radar Republic Services (RSG) is drawing fresh attention after several research firms issued more positive outlooks and institutional investors lifted their positions, following strong Q4 results and upbeat 2026 guidance. Alongside this, the company is emphasizing margin expansion and rolling out electric vehicles, while leaning on its essential waste and recycling services, which has contributed to a shift in overall sentiment toward the...
NYSE:ASAN
NYSE:ASANSoftware

Why Asana (ASAN) Is Down 11.3% After CFO Shift, Buybacks And New AI-Focused Strategy - And What's Next

In early March 2026, Asana announced a series of leadership changes, including a new Chief Financial Officer and Chief Accounting Officer, alongside fourth-quarter and full-year results showing higher revenues and lower net losses, completion of a US$210.6 million share repurchase program, and a new US$97.78 million shelf registration for employee stock offerings. Together with fresh revenue guidance for fiscal 2027 and expanded AI-driven product initiatives, these moves point to an...
NYSE:FHI
NYSE:FHICapital Markets

Assessing Federated Hermes (FHI) Valuation As Shares Track Strong Recent Returns

What Federated Hermes Stock Data Tells You Right Now Federated Hermes (FHI) is on investor watch after recent price moves, with the stock closing at US$56.99 and showing positive returns over the past week, month and past 3 months. See our latest analysis for Federated Hermes. The recent 1-day share price return of 0.78% builds on a 90-day share price return of 9.39%, while the 1-year total shareholder return of 48.13% suggests that momentum has been strong over both shorter and longer...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

What PDF Solutions (PDFS)'s Margin Gains and Analytics Pivot Means For Shareholders

Earlier in March 2026, PDF Solutions reported a strong fourth-quarter 2025 performance, with revenue growth and higher gross margins following management’s update on its evolving business model and expanding role in networking and scaled analytics across the semiconductor ecosystem. An interesting angle is how PDF Solutions is increasingly positioning its analytics and networking offerings as core infrastructure for semiconductor supply-chain collaboration and manufacturing...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio‑Techne (TECH) Valuation Check After Earnings Beat And Renewed Institutional Interest

Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier. See our latest analysis for Bio-Techne. Despite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Is Down 11.9% After MRD-Led Earnings Beat And Tax-Driven Insider Sales - Has The Bull Case Changed?

In March 2026, Adaptive Biotechnologies reported fourth-quarter 2025 results that beat analyst expectations, with revenue growth led by its Minimal Residual Disease (MRD) business, while several senior executives sold shares largely to cover tax obligations linked to vested equity awards. This combination of stronger MRD performance and insider sales tied mainly to tax withholding offers insight into how operational momentum and routine executive transactions can coexist without necessarily...
NYSE:BCC
NYSE:BCCTrade Distributors

Does Boise Cascade’s (BCC) Lean Inventory Strategy Hint at Lasting Efficiency Gains or Hidden Constraints?

Recently, Boise Cascade reported quarterly earnings and revenue that came in ahead of analyst expectations, even as it faced typical seasonal softness and broader market headwinds in its building products markets. The company also highlighted progress on its Thorsby i-line expansion, disciplined operational controls, and lean channel inventories, which together point to a tighter, more efficient operating base for its engineered wood and distribution businesses. Next, we'll examine how this...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Will Revolve Los Angeles Launch Redefine Revolve Group’s (RVLV) Luxury Brand Narrative?

In March 2026, Revolve Group, Inc. launched Revolve Los Angeles, its first namesake fashion house, debuting a XXS–XL collection priced around US$200–US$3,500 and sold exclusively on Revolve and FWRD. The move expands Revolve’s in-house brand portfolio into higher-end, couture-influenced ready-to-wear, potentially deepening customer engagement around luxury, Los Angeles-inspired fashion. Next, we’ll examine how Revolve Los Angeles, as a higher-end in-house label, could influence Revolve...
NYSE:HESM
NYSE:HESMOil and Gas

Did Hess Midstream’s (HESM) Debt-Funded Buyback Just Redefine Its Capital Return Strategy?

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...
NYSE:MC
NYSE:MCCapital Markets

Do Moelis’ (MC) Strong Earnings and Neutral Ratings Point To Different Stories On Margins?

In recent days, Moelis & Company reported strong Q4 earnings and highlighted its strongest coverage platform to date, with management emphasizing momentum and long-term value creation. At the same time, several major banks reiterated neutral views on Moelis, revealing a tension between upbeat internal commentary and cautious external assessments. Next, we'll examine how upbeat earnings alongside cautious analyst sentiment may influence Moelis' existing investment narrative around growth...